ANG1005, a novel brain-penetrant taxane derivative, for the treatment of recurrent brain metastases and leptomeningeal carcinomatosis from breast cancer.

Priya Kumthekar, Nuhad K. Ibrahim, Andrew Brenner et al.|Journal of Clinical Oncology|2016

Cited by 22